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Differentiating infection in vaccinated animals
Work Package 4.3 DIVA diagnostics
TASKS:
1. Validation of DIVA diagnostics √
2. Development of confirmatory tests √
3. Implementation of DIVA diagnostics 
for existing vaccines √
4. Build networks to improve DIVA 
diagnostics √
Serologic DIVA diagnostics:
BTV DIVA diagnostics: 
•The first results obtained indicate that BTV-inactivated 
vaccines used in the field are not free of NS 2 and 3 
proteins. A better purification of these vaccines is 
necessary to develop this kind of DIVA strategy. 
Genetic CSFV DIVA 
diagnostics:
Animals vaccinated
with live vaccines may
become viremic. 
Several real-time RT-
PCR methods have 
been published for 
differentiation of C-
strains from Classical
swine fever virus wild-
types.
How was dissemination?
Three workshops on FMD NSP for stakeholders 
and authorities during 2007
Joint international publications on DIVA 
diagnostics and a review on DIVA diagnostics
www.epizone-eu.net
EC Network of Excellence for  
epizootic disease 
diagnosis and control
DIVA vaccines and diagnostics will improve the 
vaccinate-to-live strategy for domestic livestock as 
well as free ranging animals. 
Safe trade of healthy, vaccinated animals.
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•NS1 antibodies are not detected in vaccinated animals.
CSFV DIVA diagnostics: 
•For the evaluation of CSFV Antibody ELISAs seven 
commercially available test kits from seven providers 
were tested in five CSF reference laboratories. 
•New expression systems are being tried for production 
of antigens for serological tests. 
•New detection systems for multiplex assays are 
analysed.
•New chimeric pestivirus vaccines are currently 
validated.
FMDV DIVA diagnostics: 
•Existing ELISA for the detection of antibodies to FMDV 
NSP test (3ABC-trapping ELISA) has been optimized. 
This work led to the availability of a ready-to-use, stable 
kit, then usable also in poorly equipped laboratories.
• Confirmatory tests based on IgA in saliva are developed.
HPAI DIVA diagnostics:
•An inter-laboratory evaluation of a commercial DIVA 
kit was performed. There was good specificity and fair 
sensitivity when tested by 8 EPIZONE partners.
National publications and presentations on 
DIVA diagnostics has improved awareness
National and EU funding for DIVA vaccines and 
diagnostics has been achieved
Thanks to all 
partners for 
their enthusiam
